7729.TWO
Price:
$42.35
Market Cap:
$2.82B
Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include stemchymal, stemchymal therapeutic advantages and stemchymal application fields. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2024-03-11
Stock Exchange
TWO
Ticker
7729.TWO
According to Steminent Biotherapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.41. This represents a change of 365.51% compared to the average of -3.53 of the last 4 quarters.
The mean historical PE Ratio of Steminent Biotherapeutics Inc. over the last ten years is -17.44. The current -16.41 PE Ratio has changed 9.31% with respect to the historical average. Over the past ten years (40 quarters), 7729.TWO's PE Ratio was at its highest in in the December 2022 quarter at 0. The PE Ratio was at its lowest in in the June 2023 quarter at -12.03.
Average
-17.44
Median
-13.62
Minimum
-36.76
Maximum
-7.56
Discovering the peaks and valleys of Steminent Biotherapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.33%
Maximum Annual PE Ratio = -7.56
Minimum Annual Increase = -71.89%
Minimum Annual PE Ratio = -36.76
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.56 | -44.48% |
| 2023 | -13.62 | -28.09% |
| 2022 | -18.94 | 83.33% |
| 2021 | -10.33 | -71.89% |
The current PE Ratio of Steminent Biotherapeutics Inc. (7729.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.38
5-year avg
-17.44
10-year avg
-17.44
Steminent Biotherapeutics Inc.’s PE Ratio is greater than TaiRx, Inc. (-17.86), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-38.51), less than GlycoNex Incorporation (-11.61), less than Intech Biopharm Corporation (-6.72), less than Taiwan Bio Therapeutics Co., Ltd (-5.63), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.96), less than HeXun Biosciences Co., Ltd. (15.45), less than Hcmed (-12.59), greater than Sinew Pharma Inc. (-19.44), less than Sunny Pharmtech Inc. (-7.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -17.86 | $2.54B | |
| -38.51 | $2.70B | |
| -11.61 | $2.33B | |
| -6.72 | $2.46B | |
| -5.63 | $2.29B | |
| -28.96 | $2.62B | |
| 15.45 | $2.56B | |
| -12.59 | $2.29B | |
| -19.44 | $2.77B | |
| -7.79 | $2.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Steminent Biotherapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Steminent Biotherapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Steminent Biotherapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the highest PE Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 3-year average PE Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 5-year average PE Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
How does the current PE Ratio for Steminent Biotherapeutics Inc. (7729.TWO) compare to its historical average?